Condition: Coronary Arterial Disease (CAD) · Restenosis, Coronary · Bifurcation Coronary Disease · Sponsor: Olivier F. Bertrand
Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.
This description comes directly from the study's public registry record.
Michele Jadin · 418-6568711 · michele.jadin@criucpq.ulaval.ca
Always discuss trial participation with your own doctor first.
| IUCPQ | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06972225